Zogenix

$22.23
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.15 (+0.68%) As of 1:26 PM EST today

Why Robinhood?

You can buy or sell Zogenix and other stocks, options, and ETFs commission-free!

About ZGNX

Zogenix, Inc. Common Stock, also called Zogenix, is a pharmaceutical company. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. The listed name for ZGNX is Zogenix, Inc. Common Stock.

CEO
Stephen James Farr
Employees
141
Headquarters
Emeryville, California
Founded
2006
Market Cap
1.23B
Price-Earnings Ratio
Dividend Yield
Average Volume
728.56K
High Today
$22.80
Low Today
$22.13
Open Price
$22.16
Volume
328.47K
52 Week High
$57.22
52 Week Low
$16.65

Collections

ZGNX Earnings

-$1.18
-$0.79
-$0.39
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 1, After Hours

You May Also Like